RxDoctor Payments DataLook up a doctor →

Derek Jones, DO

Family Medicine · Ashland, KYNPI 1477754919

Payments from drug & device makers

$36,792in general payments, 2019–2025

Across 1,107 payments — averaging $33.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$22K
  • AbbVie$3K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • AstraZeneca$1K
  • plus $6K from 51 others

What the payments were for

  • Speaking & faculty fees$21,25058%
  • Food & beverage$15,51742%
  • Education$60%
  • Entertainment$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson71$22,224
AbbVie(2 entities)245$2,599
Novo Nordisk165$2,125
Lilly USA, LLC103$1,447
Pfizer83$1,275
AstraZeneca55$1,095
Merck44$598
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC35$574
GSK31$543
Kowa Pharmaceuticals America, Inc.22$274
Mylan Specialty L.p.10$266
Astellas Pharma US Inc13$255
Biohaven Pharmaceutical Holding Company Ltd.28$249
Shield Therapeutics Inc6$248
Boehringer Ingelheim17$225
Esperion Therapeutics, Inc.11$185
Axsome Therapeutics, Inc.8$174
Biohaven Pharmaceuticals, Inc.17$161
Amarin Pharma, Inc.12$159
Teva Pharmaceuticals USA, Inc.10$148
Aimmune Therapeutics, Inc.9$144
Dexcom, Inc.8$137
Amgen7$113
Abbott6$110
Novartis7$107
Otsuka America Pharmaceutical, Inc.5$100
Sanofi-aventis U.S. LLC6$98
Corcept Therapeutics6$97
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$91
Bayer6$89
Phathom Pharmaceuticals, Inc.4$74
Exact Sciences4$73
Xeris Pharmaceuticals, Inc.4$72
Sunovion Pharmaceuticals Inc.4$69
Arbor Pharmaceuticals, Inc.5$64
IBSA Pharma Inc.3$46
E.r. Squibb & Sons, L.L.C.3$45
Nestle Healthcare Nutrition Inc.3$39
Lundbeck LLC2$35
Supernus Pharmaceuticals, Inc.2$32
Sumitomo Pharma America, Inc.2$31
Optinose US, Inc.2$31
Assertio Therapeutics, Inc.2$27
Currax Pharmaceuticals LLC2$26
Shire North American Group Inc2$24
Seqirus USA Inc1$21
Alnylam Pharmaceuticals Inc.1$21
Abiomed1$21
Optos, Inc.1$19
Ultragenyx Pharmaceutical Inc.1$18
Daiichi Sankyo Inc.1$16
Takeda Pharmaceuticals U.S.A., Inc.1$15
Upsher-smith Laboratories LLC1$14
Eisai Inc.1$13
Avanir Pharmaceuticals, Inc.1$12
Ironwood Pharmaceuticals, Inc1$12
Redhill Biopharma Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,792 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$146,090
Medicare patients
244
Services billed
2,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Penicillamine11$107,472
OzempicSemaglutide70$95,991
MounjaroTirzepatide72$94,918
FarxigaDapagliflozin Propanediol65$64,440
EliquisApixaban65$63,111
XareltoRivaroxaban48$48,149
Tresiba Flextouch U-200Insulin Degludec31$34,960
TrulicityDulaglutide26$27,473
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$25,678
JardianceEmpagliflozin25$23,364
JanuviaSitagliptin Phosphate18$20,717
Ondansetron Hcl51$13,917
DapagliflozinDapagliflozin Propanediol12$12,730
Emgality PenGalcanezumab-Gnlm16$10,968
Humalog Kwikpen U-100Insulin Lispro12$8,923

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,447$122,39098 claims
Novo NordiskOzempic$2,125$95,99170 claims
AstraZenecaFarxiga, Nexium, Breztri Aerosphere$1,095$79,66087 claims
PfizerEliquis$1,275$63,11165 claims
Johnson & JohnsonXarelto$22,224$48,14948 claims
GSKTrelegy Ellipta$543$25,67820 claims
Boehringer IngelheimJardiance$225$23,36425 claims
MerckJanuvia$598$20,71718 claims
AbbVieSynthroid$2,599$2,45648 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →